CELLYTX Trademark

Trademark Overview


On Monday, January 9, 2023, a trademark application was filed for CELLYTX with the United States Patent and Trademark Office. The USPTO has given the CELLYTX trademark a serial number of 97746426. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 4, 2024. This trademark is owned by Cellarity, Inc.. The CELLYTX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; scientific research in the field of drug discovery and development; biomedical research services; bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development
cellytx

General Information


Serial Number97746426
Word MarkCELLYTX
Filing DateMonday, January 9, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
Goods and ServicesResearch and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; scientific research in the field of drug discovery and development; biomedical research services; bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to drug development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 31, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellarity, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Party NameCellarity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Friday, October 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, January 12, 2023NEW APPLICATION ENTERED
Tuesday, January 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 21, 2023ASSIGNED TO EXAMINER
Friday, July 28, 2023NON-FINAL ACTION WRITTEN
Friday, July 28, 2023NON-FINAL ACTION E-MAILED
Friday, July 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 21, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 21, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 21, 2024ASSIGNED TO LIE
Wednesday, February 21, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT